Markets
Labs by Hims
Hims & Hers’ Labs app (Hims & Hers)

Hims & Hers launches blood test analysis product

Hims expects to introduce more specs, including at-home testing devices, over time.

J. Edward Moreno

Hims & Hers announced the launch of a lab-testing product it says will analyze bloodwork and suggest custom health plans.

The product, called “Labs,” will allow users to upload bloodwork and suggest “doctor-developed action plans,” which may include suggestions for medication that is sold by Hims or its partners.

The product has two tiers: a base plan that costs $199 a year or an advanced plan for $499 a year. The base plan comes with one blood draw a year, while the advanced comes with two and measures more biomarkers. Similar products are sold by startups like Function Health and Lifeforce.

The testing is being done through a partnership with Quest Diagnostics. Hims expects to introduce more specs, including at-home testing devices, over time. The company acquired an at-home blood-testing facility, Trybe Labs, in February, which is being used to onboard patients in Hims’ new hormone treatment segments.

Hims was down about 6% leading up to the announcement and stayed around there after the announcement.

The announcement comes as Hims investors have grown increasingly gloomy, with many momentum stocks like Hims having pulled back sharply of late. Hims is down 40% since October 15, when it announced it would expand its product lineup to offer menopause treatments.

The company has been looking for ways to spark sales growth as its core sexual health business slows down and its ability to sell weight-loss treatments remains on shaky ground. Its expansion into hormone treatments has sparked short-lived rallies, but other signs, like executive stock sales and the sudden departure of its newly appointed chief operating officer, Amazon alum Nader Kabbani, have given investors pause.

More Markets

See all Markets
Tasha Matsumoto
6h
Hedging the AI trade and crypto with futures

As anxiety over the AI trade increases and volatility in crypto spikes, traders who are worried about downswings can manage risk with futures.

Greedy Man With Blue Skull - stock illustration
markets
Rani Molla

Amazon just matched its longest losing streak in 20 years

Amazon shares marked their ninth straight day of losses — the company’s longest losing streak since 2006.

The milestone follows a fourth-quarter earnings miss, downbeat guidance, and a plan to spend a whopping $200 billion on capital expenditure this year.

Amazon is hoping that by spending big on AI infrastructure now, it will reap rewards from the technology later. Investors aren’t so sure.

Interestingly enough, the current situation sounds quite similar to the one Amazon was in two decades ago. Back then, Amazon endured a similar stretch as it was upping spending on tech and an online toy store — moves that would eat into its profits.

At the time, an asset manager told Bloomberg, “They want to capture as many eyeballs as they can on the Internet and be the go-to place on the Internet, but that’s costing them earnings, at least right now.”

Sound familiar? In case you’re wondering, Amazon stock has risen 14,849% since that quote.

Tasha Matsumoto
7h
Stocks lose steam after in-line January inflation report

Most Mag 7 stocks declined, but the Russell 2000 outperformed, rising 1.2%.

BISHOP'S STORTFORD, ENGLAND - JANUARY 25: Snowfall in the Essex countryside on January 25, 2021 in Bishop's Stortford, Essex, United Kingdom.
markets
Max Knoblauch

Rivian is on pace for its best-ever trading day as analysts dig into Q4 results

EV maker Rivian is on track to log its best trading day on record Friday, as investors pour in following its fourth-quarter earnings report and 2026 guidance and analysts issue bullish appraisals of the shares.

Rivian shares are up more than 30% on Friday afternoon, easily surpassing its previous best trading day, which came in January 2025.

“We continue to remain confident in the long-term vision that RIVN is amid a massive transformation,” Wedbush Securities’ Dan Ives wrote in a fresh note on Friday. The firm maintained its $25 price target and “outperform” outlook and said that the launch of Rivian’s upcoming lower-cost SUV, the R2, is “crucial.”

Rivian received upgrades from Deutsche Bank (to “buy” from “hold”) and UBS (to “neutral” from “sell”) following its results.

On its Thursday earnings call, Rivian said it expects its delivery volume of its existing vehicle lineup to land “roughly in line with... 2025 total volumes.” Given the automaker’s full-year delivery guidance, that statement implies 2026 R2 deliveries to land between 20,000 and 25,000 units.

Self-driving features also appear to be boosting investor optimism. On Thursday’s earnings call, CEO RJ Scaringe said the company would enable “point-to-point” driving in its vehicles later this year. In a podcast interview released Thursday, Scaringe predicted that by 2030, it will be “inconceivable to buy a car and not expect it to drive itself.” Rivian is targeting “a little sooner than that,” he added.

Rivian shares are also likely benefiting from something of a snapback: before the release of its Q4 results, Rivian shares had been hammered recently, down 38% since their recent high in December.

Rivian climbs after posting better-than-expected Q4 results; sees R2 SUV hitting the market in Q2

Rivian climbs after posting better-than-expected Q4 results; sees R2 SUV hitting the market in Q2

“We continue to remain confident in the long-term vision that RIVN is amid a massive transformation,” Wedbush Securities’ Dan Ives wrote in a fresh note on Friday. The firm maintained its $25 price target and “outperform” outlook and said that the launch of Rivian’s upcoming lower-cost SUV, the R2, is “crucial.”

Rivian received upgrades from Deutsche Bank (to “buy” from “hold”) and UBS (to “neutral” from “sell”) following its results.

On its Thursday earnings call, Rivian said it expects its delivery volume of its existing vehicle lineup to land “roughly in line with... 2025 total volumes.” Given the automaker’s full-year delivery guidance, that statement implies 2026 R2 deliveries to land between 20,000 and 25,000 units.

Self-driving features also appear to be boosting investor optimism. On Thursday’s earnings call, CEO RJ Scaringe said the company would enable “point-to-point” driving in its vehicles later this year. In a podcast interview released Thursday, Scaringe predicted that by 2030, it will be “inconceivable to buy a car and not expect it to drive itself.” Rivian is targeting “a little sooner than that,” he added.

Rivian shares are also likely benefiting from something of a snapback: before the release of its Q4 results, Rivian shares had been hammered recently, down 38% since their recent high in December.

Screaming Man

Safety is the only thing that’s worked in the stock market

Luke Kawa10h

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.
©2026 Sherwood Media, LLC